Literature DB >> 22740531

Epidemiology and potential land-sea transfer of enteric bacteria from terrestrial to marine species in the Monterey Bay Region of California.

Stori C Oates1, Melissa A Miller, Barbara A Byrne, Nadira Chouicha, Dane Hardin, David Jessup, Clare Dominik, Annette Roug, Alexander Schriewer, Spencer S Jang, Woutrina A Miller.   

Abstract

Marine mammals are at risk for infection by fecal-associated zoonotic pathogens when they swim and feed in polluted nearshore marine waters. Because of their tendency to consume 25-30% of their body weight per day in coastal filter-feeding invertebrates, southern sea otters (Enhydra lutris nereis) can act as sentinels of marine ecosystem health in California. Feces from domestic and wildlife species were tested to determine prevalence, potential virulence, and diversity of selected opportunistic enteric bacterial pathogens in the Monterey Bay region. We hypothesized that if sea otters are sentinels of coastal health, and fecal pollution flows from land to sea, then sea otters and terrestrial animals might share the same enteric bacterial species and strains. Twenty-eight percent of fecal samples tested during 2007-2010 were positive for one or more potential pathogens. Campylobacter spp. were isolated most frequently, with an overall prevalence of 11%, followed by Vibrio cholerae (9%), Salmonella spp. (6%), V. parahaemolyticus (5%), and V. alginolyticus (3%). Sea otters were found positive for all target bacteria, exhibiting similar prevalences for Campylobacter and Salmonella spp. but greater prevalences for Vibrio spp. when compared to terrestrial animals. Fifteen Salmonella serotypes were detected, 11 of which were isolated from opossums. This is the first report of sea otter infection by S. enterica Heidelberg, a serotype also associated with human clinical disease. Similar strains of S. enterica Typhimurium were identified in otters, opossums, and gulls, suggesting the possibility of land-sea transfer of enteric bacterial pathogens from terrestrial sources to sea otters.

Entities:  

Mesh:

Year:  2012        PMID: 22740531     DOI: 10.7589/0090-3558-48.3.654

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  6 in total

1.  Prevalence, environmental loading, and molecular characterization of Cryptosporidium and Giardia isolates from domestic and wild animals along the Central California Coast.

Authors:  Stori C Oates; Melissa A Miller; Dane Hardin; Patricia A Conrad; Ann Melli; David A Jessup; Clare Dominik; Annette Roug; M Tim Tinker; Woutrina A Miller
Journal:  Appl Environ Microbiol       Date:  2012-10-05       Impact factor: 4.792

2.  Dynamics of Vibrio with virulence genes detected in Pacific harbor seals (Phoca vitulina richardii) off California: implications for marine mammal health.

Authors:  Stephanie N Hughes; Denise J Greig; Woutrina A Miller; Barbara A Byrne; Frances M D Gulland; James T Harvey
Journal:  Microb Ecol       Date:  2013-02-08       Impact factor: 4.552

3.  A new pathogen transmission mechanism in the ocean: the case of sea otter exposure to the land-parasite Toxoplasma gondii.

Authors:  Fernanda F M Mazzillo; Karen Shapiro; Mary W Silver
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

4.  Nascent Genomic Evolution and Allopatric Speciation of Myroides profundi D25 in Its Transition from Land to Ocean.

Authors:  Yu-Zhong Zhang; Yi Li; Bin-Bin Xie; Xiu-Lan Chen; Qiong-Qiong Yao; Xi-Ying Zhang; Megan L Kempher; Jizhong Zhou; Aharon Oren; Qi-Long Qin
Journal:  MBio       Date:  2016-01-12       Impact factor: 7.867

5.  Prevalence and Antimicrobial Resistance of Bacteria Isolated from Marine and Freshwater Fish in Tanzania.

Authors:  Esther Marijani
Journal:  Int J Microbiol       Date:  2022-03-04

6.  An Innovative Method for Rapid Identification and Detection of Vibrio alginolyticus in Different Infection Models.

Authors:  Kaifei Fu; Jun Li; Yuxiao Wang; Jianfei Liu; He Yan; Lei Shi; Lijun Zhou
Journal:  Front Microbiol       Date:  2016-05-06       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.